South Korean EV battery makers agree to end a $1.8bn row

Photo: AP

The leading South Korean producers of batteries for electric vehicles SK Innovation and LG Chem announced they had reached an agreement to end a $1.8bn worth painful dispute, Reuters reported. The deal will facilitate the efforts of the two firms t stay on top of battery developments. LG Energy Solution, a wholly owned subsidiary of LG Chem, and SK Innovation also agreed to drop all litigation in the United States and South Korea and not to sue each other for 10 years, after the core dispute had threatened the EV plans of Ford and Volkswagen.

“This agreement has resolved uncertainties about the growth of the battery business and our pursuit of the US market,” SK Innovation CEO Kim Jun said in a message to employees seen by Reuters. “It will enable us to accelerate the construction of the Georgia, US plant and actively promote additional investment and cooperation in line with the development of the US and global EV industry.” Ford said in a statement that it was pleased the battery makers had settled their differences, and that the agreement allowed Ford to focus on delivering EVs for retail and fleet customers. However, analysts said the companies’ lawsuit-free future partly depended on how they responded to Volkswagen’s decision last month to move the bulk of its cars to a new unified prismatic battery and away from the pouch-style manufactured by LG and SK - although Volkswagen’s shift doesn’t mean other automakers will follow.

Similar articles

  • Covid-19 vaccine makers slump on expected patent waiver

    Covid-19 vaccine makers slump on expected patent waiver

    The stocks of all companies involved in production of Covid-19 vaccines fell, as US and EU backed the call from the World Health Organisation to waive patent rights claims over the jabs production, Reuters reported. The share slumps came even as some analysts raised doubts about any near-term pressure on Covid-19 vaccine sales from discussions of waiving intellectual property rights, given the manufacturing complexity and scarcity of raw materials. Combined, Pfizer and Moderna have forecast a total of over $45 billion in sales this year for their Covid-19 vaccines.

    37
  • Tesla misses key technology target

    Tesla misses key technology target

    The producer of electric cars Tesla admitted it would miss a target set by its majority owner Elon Musk - to develop full self-driving vehicles by the end of 2021, Reuters reported. The announcement seriously undermines Tesla ambitions to influence the global EV market. Documents released in media earlier this week showed that the company is falling behind announced deadlines while incidents with EVs continue to rise.

    28
  • Bayer loses court fight over EU pesticides

    Bayer loses court fight over EU pesticides

    The German chemical conglomerate Bayer lost an appeal in EU court against a ban related to the usage of pesticides amid growing concerns linked to the extinction on bees, Reuters reported. The European Union's top court upheld the EU's partial ban on insecticides linked to harming bees, preventing their use on certain crops. Bayer appealed to overturn a lower EU court's 2018 decision to uphold the EU ban.

    61